Akers Biosciences, Inc. (AKR)

Sector:

Health Care

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 105.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 245.00
  • 52 Week Low: 100.00
  • Currency: UK Pounds
  • Shares Issued: 8.90m
  • Volume: 0
  • Market Cap: 9.34m
  • RiskGrade: 273

AKR Overview

Akers Biosciences, Inc. is in the health care sector and is currently trading at 105.00p per share. In the last year Akers Biosciences, Inc. 's share price has ranged from 100.00p to 245.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -112.5% -29.9%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 4.0 2.4
Pr/Book 3.5  
Latest F'cast
Revenue 39.6% 2.3%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

AKR Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 1.56 (2.73) (224.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-13 3.58 (1.53) (95.62)¢ n/a n/a n/a n/a 0.0%
31-Dec-14 4.43 (3.13) (66.23)¢ n/a n/a n/a n/a 0.0%
31-Dec-15 2.12 (9.58) (181.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-16 2.96 (3.30) (61.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AKR Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 3.86 (1.15) (16.22)p n/a n/a n/a n/a 0.0%
31-Dec-18 8.26 2.38 26.26p 4.0 n/a n/a n/a 0.0%

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.

AKR Company Announcements

Issue of Equity 09-Jun-2017 16:51 RNS
1st Quarter Results 16-May-2017 07:00 RNS
Notice of Q1 Results 12-May-2017 14:30 RNS

Latest AKR Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

AKR Market Data

Currency UK Pounds
Share Price 105.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 245.00
52 Week Low 100.00
Volume 0
Shares Issued 8.90m
Market Cap 9.34m
RiskGrade 273

AKR Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
54.28% below the market average54.28% below the market average54.28% below the market average54.28% below the market average54.28% below the market average
29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average
Price Trend
6.90% above the market average6.90% above the market average6.90% above the market average6.90% above the market average6.90% above the market average
76.47% below the sector average76.47% below the sector average76.47% below the sector average76.47% below the sector average76.47% below the sector average
Income Not Available
Growth
58.47% above the market average58.47% above the market average58.47% above the market average58.47% above the market average58.47% above the market average
3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AKR Dividends

No dividends found

Trades for --2017

Time Volume / Share Price
0 @ 0.000p

AKR Key Personnel

Chair Thomas Knox
CEO John J. Gormally

Top of Page